Characterisation of healthcare utilisation and cost of haemophilia care in real-life: A 4-year follow-up study in Finland.
Hanna VentolaAino VesikansaJari JokelainenTimo SiitonenPia EttalaOuti LaineElina LehtinenAino LepäntaloMaria PatronenAnu PartanenMiika LinnaTero Ylisaukko-OjaRiitta LassilaPublished in: Haemophilia : the official journal of the World Federation of Hemophilia (2020)
The outcomes of centralising the management of care to University Hospital Treatment Centres show low ABR and lower treatment costs compared with earlier reports from other high-income European populations. Management strategies, including choosing the right therapy between prophylaxis and on-demand, has been successful in Finland.